Lai F M, Tanikella T, Herzlinger H, Goldstein B, Chan P S, Cervoni P
Clin Exp Hypertens A. 1982;4(6):1001-18. doi: 10.3109/10641968209060768.
Captopril (30 mg/kg/day orally for two days) in spontaneously hypertensive rats (SHR) inhibited serum angiotensin converting enzyme (ACE) activity 92.3%; increased plasma renin activity (PRA) 18-fold and reduced mean arterial blood pressure (MABP) 19 mm Hg. Hydrochlorothiazide (HCTZ) (100 mg/kg-day 1; 10 mg/kg-day 2, orally) increased PRA 3-fold but did not affect serum ACE or MABP. HCTZ plus captopril inhibited serum ACE 95.2%; increased PRA 38-fold and reduced MABP 47.5 mm Hg. Captopril or HCTZ plus captopril did not alter the responses of isolated aortic strips to norepinephrine (NE), serotonin, angiotensin II (AII) or isoproterenol. Pressor responses of conscious SHR to AII and NE were unaltered by captopril or HCTZ plus captopril although the bradykinin-induced depressor responses were significantly but equally potentiated. These results suggest that the potentiating effect of HCTZ is due to some mechanism that shifts the animal's blood pressure maintenance system to a renin-dependent state and is not due to changes in vascular reactivity.
卡托普利(30毫克/千克/天,口服,共两天)对自发性高血压大鼠(SHR)血清血管紧张素转换酶(ACE)活性的抑制率为92.3%;使血浆肾素活性(PRA)升高18倍,并使平均动脉血压(MABP)降低19毫米汞柱。氢氯噻嗪(HCTZ)(第1天100毫克/千克,第2天10毫克/千克,口服)使PRA升高3倍,但不影响血清ACE或MABP。HCTZ加卡托普利抑制血清ACE达95.2%;使PRA升高38倍,并使MABP降低47.5毫米汞柱。卡托普利或HCTZ加卡托普利不改变离体主动脉条对去甲肾上腺素(NE)、5-羟色胺、血管紧张素II(AII)或异丙肾上腺素的反应。尽管缓激肽诱导的降压反应被显著且同等程度地增强,但清醒SHR对AII和NE的升压反应不受卡托普利或HCTZ加卡托普利的影响。这些结果表明,HCTZ的增强作用是由于某种机制使动物的血压维持系统转变为肾素依赖状态,而不是由于血管反应性的改变。